The design and optimization of a series of 2-(pyridin-2-yl)-1H-benzimidazole compounds as allosteric glucokinase activators

Add time:09/10/2019    Source:sciencedirect.com

The optimization of a series of benzimidazole glucokinase activators is described. We identified a novel and potent achiral benzimidazole derivative as an allosteric GK activator. This activator was designed and synthesized via removal of the chiral center of the lead compound, 6-(N-acylpyrrolidin-2-yl)benzimidazole. The activator exhibited good PK profiles in rats and dogs, and significant hypoglycemic efficacy at 1 mg/kg po dosing in a rat OGTT model. The binding site and binding mode of the benzimidazole class of GKA with GK protein was confirmed by X-ray crystallographic analysis.

We also recommend Trading Suppliers and Manufacturers of 1H-BENZIMIDAZOLE, 4-FLUORO-2-METHYL- (cas 18645-89-1). Pls Click Website Link as below: cas 18645-89-1 suppliers

Prev:Short communicationSynthesis and antiprotozoal activity of some 2-(trifluoromethyl)-1H-benzimidazole bioisosteres
Next:Original articleSynthesis and biological activity of novel inhibitors of topoisomerase I: 2-Aryl-substituted 2-bis-1H-benzimidazoles)